Back to Agenda
FDA Town Hall
Session Chair(s)
Kim Quaintance-Lunn
Vice President, Head of Regulatory Science and Execution, Alexion Pharmaceuticals, United States
The FDA Town Hall is the forum to hear from FDA leadership about Center priorities. The audience will be invited to submit questions of general interest.
Learning Objective : Discuss FDA Center priorities.
Speaker(s)
Kevin Bugin, MS, RAC
Head of Global Regulatory Policy and Intelligence, Amgen, United States
Panelist
Julia Tierney, JD
Principal, Leavitt Partners, United States
Panelist
Anindita Saha
Associate Director Strategic Initiatives, Digital Health Center of Excellence, C, FDA, United States
Panelist
Tamy Kim, PHARMD
Director, Regulatory Affairs/ Regulatory Policy, Oncology Center of Excellence, FDA, United States
Panelist
Have an account?